全文获取类型
收费全文 | 1346035篇 |
免费 | 99572篇 |
国内免费 | 2302篇 |
专业分类
耳鼻咽喉 | 17266篇 |
儿科学 | 43561篇 |
妇产科学 | 36972篇 |
基础医学 | 200377篇 |
口腔科学 | 36625篇 |
临床医学 | 124694篇 |
内科学 | 265329篇 |
皮肤病学 | 28969篇 |
神经病学 | 109638篇 |
特种医学 | 49940篇 |
外国民族医学 | 282篇 |
外科学 | 189863篇 |
综合类 | 27347篇 |
现状与发展 | 3篇 |
一般理论 | 613篇 |
预防医学 | 109713篇 |
眼科学 | 29333篇 |
药学 | 99082篇 |
9篇 | |
中国医学 | 2531篇 |
肿瘤学 | 75762篇 |
出版年
2021年 | 11081篇 |
2019年 | 11509篇 |
2018年 | 15331篇 |
2017年 | 11803篇 |
2016年 | 12828篇 |
2015年 | 14807篇 |
2014年 | 20278篇 |
2013年 | 30821篇 |
2012年 | 42016篇 |
2011年 | 44609篇 |
2010年 | 26076篇 |
2009年 | 24858篇 |
2008年 | 41814篇 |
2007年 | 44625篇 |
2006年 | 43969篇 |
2005年 | 42879篇 |
2004年 | 41597篇 |
2003年 | 39950篇 |
2002年 | 38883篇 |
2001年 | 58782篇 |
2000年 | 59698篇 |
1999年 | 50255篇 |
1998年 | 14355篇 |
1997年 | 12973篇 |
1996年 | 13340篇 |
1995年 | 12550篇 |
1994年 | 11690篇 |
1992年 | 39492篇 |
1991年 | 38938篇 |
1990年 | 37562篇 |
1989年 | 36312篇 |
1988年 | 33654篇 |
1987年 | 32901篇 |
1986年 | 31407篇 |
1985年 | 29598篇 |
1984年 | 22547篇 |
1983年 | 19747篇 |
1982年 | 11712篇 |
1979年 | 21407篇 |
1978年 | 15739篇 |
1977年 | 13082篇 |
1976年 | 12127篇 |
1975年 | 13138篇 |
1974年 | 15975篇 |
1973年 | 15736篇 |
1972年 | 14852篇 |
1971年 | 13858篇 |
1970年 | 13065篇 |
1969年 | 12351篇 |
1968年 | 11506篇 |
排序方式: 共有10000条查询结果,搜索用时 15 毫秒
111.
112.
Arjenne H.M. Gussenhoven Amika S. Singh S. Theo Goverts Marten van Til Johannes R. Anema Sophia E. Kramer 《International journal of audiology》2015,54(8):507-517
Objective: A multidisciplinary vocational rehabilitation programme, the Vocational Enablement Protocol (VEP) was developed to address the specific needs of employees with hearing difficulties. In the current study we evaluated the process of implementing the VEP in audiologic care among employees with hearing impairment. Design: In conjunction with a randomized controlled trial, we collected and analysed data on seven process parameters: recruitment, reach, fidelity, dose delivered, dose received and implemented, satisfaction, and perceived benefit. Study sample: Sixty-six employees with hearing impairment participated in the VEP. The multidisciplinary team providing the VEP comprised six professionals. Results: The professionals performed the VEP according to the protocol. Of the recommendations delivered by the professionals, 31% were perceived as implemented by the employees. Compliance rate was highest for hearing-aid uptake (51%). Both employees and professionals were highly satisfied with the VEP. Participants rated good perceived benefit from it. Conclusions: Our results indicate that the VEP could be a useful treatment for employees with hearing difficulties from a process evaluation perspective. Implementation research in the audiological setting should be encouraged in order to further provide insight into parameters facilitating or hindering successful implementation of an intervention and to improve its quality and efficacy. 相似文献
113.
114.
Maria Ricci Agostino Chiaravalloti Alessandro Martorana Giacomo Koch Vincenzo De lucia Gaetano Barbagallo Orazio Schillaci 《Annals of nuclear medicine》2020,34(4):254-262
The aim of our study was to investigate the impact of the epsilon phenotype in brain glucose consumption in a population with Alzheimer’s disease. Statistical Parametric Mapping (SPM8) was used to investigate differences in brain glucose consumption (as detectable by means of 18F FDG-PET/CT) in the population examined. A total of 129 patients (72 females and 57 males) with a diagnosis of probable AD according to the NINCDS-ADRDA criteria underwent the PET/CT examination. The mean (SD) age of the patients was 70 (± 7) years; the mean Mini-Mental State Examination was 19(± 5.6). 59 expressed epsilon 4 phenotype (E4) and 70 expressed the epsilon 3 phenotype (E3). Cerebral spinal fluid amyloid, tau, and t-tau have been measured resulting equal to 367.4 (± 149.1), 584.7 (± 312.1), and 79.2(± 45.9) pg/ml, respectively. Patients with confirmed amyloid and Tau changes were classified as AD. Patients with amyloid changes but negative Tau, considered as high risk of AD, were classified as IAD. Age, sex, MMSE, scholarship, and CSF parameters were used as a covariate in the SPM analyses. We did not find significant differences in age, gender, and MMSE and CSF parameters among groups. In the analysis of the AD group as compared to AD-E3, AD-E4 subjects show a significant reduction of brain glucose consumption in inferior frontal gyrus bilaterally (BA 45, BA 47). In the analysis of the IAD group as compared to IAD-E3, IAD-E4 subjects show a significant reduction of brain glucose consumption in right in medial, middle, and superior frontal gyrus (BA10, BA11), and in left medial and middle frontal gyrus (BA10, BA11). The differences between IAD-E3 and AD-E3 and between IAD-E4 and AD-E4 (and vice versa analysis) resulted not significant. APO-e4 is related to a major involvement of the frontal cortex confirming its role of risk factor in AD, while APO-3 seems not related to a specific pattern, supporting the hypothesis of neutral/protective role in AD. 相似文献
115.
116.
117.
118.
Marco Maruzzo Umberto Basso Eugenio Borsatti Laura Evangelista Filippo Alongi Orazio Caffo Francesca Maines Sara Galuppo Rocco De Vivo Fable Zustovich Dario Palleschi Andrea Zivi Teodoro Sava Mariella Sorarù Roberto Iacovelli Maurizio Nicodemo Susanne Baier Lucia Fratino Vittorina Zagonel 《Clinical genitourinary cancer》2019,17(1):e187-e194
Background
Radium 223 was introduced for metastatic castration-resistant prostate cancer based on the results of a randomized controlled trial showing risk reduction for death and skeletal events. Our aim was to evaluate the outcome of patients receiving radium 223 in a real-world setting.Patients and Methods
We conducted a multicenter retrospective analysis in the Triveneto region of Italy.Results
One hundred fifty-eight patients received radium 223 in our region. After a median follow-up of 9.5 months, 75 patients died. The median overall survival (OS) was 14.2 months, and the median progression-free survival (PFS) was 6.2 months. Seventy-one (45%) patients achieved progression as best response. Thirty-seven (23%) patients stopped the treatment early because of progression. Eastern Cooperative Oncology Group performance status was prognostic for OS (18.4 vs. 12.3 vs. 7.5 months; 0 vs. 1, P = .0062; 0 vs. 2, P = .0002), whereas previous prostatectomy or docetaxel exposure were not. A neutrophil to lymphocytes ratio ≥ 3 significantly impacted OS (18.1 vs. 9.7 months; P < .001) and slightly impacted PFS (6.6 vs. 5.6 months; P = .05). Patients with a baseline alkaline phosphatase (ALP) value ≥ 220 U/L had worse OS and PFS (24.1 vs. 10.5 months; 7.2 vs. 5.5 months; P < .001). Patients with changes in ALP value achieved better OS (P = .029) and PFS (P = .002). There was no difference according to the line of therapy (0 vs. ≥ 1; P = .490). The main grade 3/4 toxicities were anemia, asthenia, and thrombocytopenia.Conclusion
This large real-world report confirms comparable OS and PFS data when compared with the pivotal study, as well as the predictive role of ALP and neutrophil to lymphocytes ratio. The definition of the optimal position of radium 223 in the treatment of metastatic castration-resistant prostate cancer has still to be defined. 相似文献119.
120.